Nivolumab, a new immunomodulatory drug, a new adverse effect; adrenal crisis.Owing to the advancements in medicine, new information is obtained regarding cancer, new antineoplastic agents are developed.  We present a case of adrenal crisis in a patient with non-small cell lung cancer (NSCLC), caused by an immunomodulatory drug; nivolumab.  While adverse events are related to other immunomodulatory drugs have been reported in literature, our case is the first nivolumab-related adrenal failure to be reported. 
nivolumab
Nivolumab, a new immunomodulatory drug, a new adverse effect; adrenal crisis.Owing to the advancements in medicine, new information is obtained regarding cancer, new antineoplastic agents are developed.  We present a case of adrenal crisis in a patient with non-small cell lung cancer (NSCLC), caused by an immunomodulatory drug; nivolumab.  While adverse events are related to other immunomodulatory drugs have been reported in literature, our case is the first nivolumab-related adrenal failure to be reported. 
nivolumab
Nivolumab, a new immunomodulatory drug, a new adverse effect; adrenal crisis.Owing to the advancements in medicine, new information is obtained regarding cancer, new antineoplastic agents are developed.  We present a case of adrenal crisis in a patient with non-small cell lung cancer (NSCLC), caused by an immunomodulatory drug; nivolumab.  While adverse events are related to other immunomodulatory drugs have been reported in literature, our case is the first nivolumab-related adrenal failure to be reported. 
nivolumab